$ILMN News
Last published 1d ago
- 1d agoILMNIllumina, Inc. - 1780182 - ILLUMINA INCEarnings Call TranscriptsAll right, good morning. I'm Doug Schenkel from UBS. It's my pleasure to welcome Jacob Thasen and Ankur Bhingra, CEO and CFO of Illumina, respectively. Thank you both for being here with us. Thanks for inviting me. Yeah.
- 2d agoILMNIllumina advances MRD research portfolio with ultrasensitive duplex sequencing technologyPR NewswireIllumina, Inc. (NASDAQ: ILMN) today announced an expansion of its molecular residual disease (MRD) research portfolio with an early access...
- 1w agoILMNILLUMINA, INC. - EX-99.1Earnings ReleasesForm 8-K - Current report - Item 2.02 Item 9.01
- 1w agoILMNIllumina Reports Financial Results for Third Quarter of Fiscal Year 2026PR NewswireSAN DIEGO, Oct. 29, 2026 /PRNewswire/ -- Illumina, Inc. (NASDAQ:ILMN) ("Illumina" or the "company") today announced its financial results for the third quarter of fiscal year 2026. Third quarter 2026
- 2w agoILMNIllumina To Webcast Upcoming Investor ConferencePR NewswireSAN DIEGO, Oct. 27, 2026 /PRNewswire/ -- Illumina, Inc. (NASDAQ:ILMN) today announced that members of its management team will participate at the following investor conference: Upcoming Investor ConferenceJefferies
- 3w agoILMNIllumina BioInsight Platform expands with new software to accelerate the path from sequencing to discoveryPR NewswireDRAGEN Ultra, BioInsight Platform Workflow Orchestrator, and BioInsight Platform Learning Cohorts are now available in early access, incorporating new AI-driven approaches to analysis, automation, and discoveryThe tools
- 3w agoILMNIllumina To Webcast Upcoming Investor ConferencePR NewswireSAN DIEGO, Oct. 20, 2026 /PRNewswire/ -- Illumina, Inc. (NASDAQ:ILMN) today announced that members of its management team will participate at the following investor conference: Upcoming Investor ConferenceUBS Global
- 4w agoILMNIllumina launches BioInsight Platform, its first unified software environment to help accelerate genomic and multiomic breakthroughsPR NewswireThe new platform brings together advanced analysis, purpose-built AI, and curated biological data so researchers can move more quickly from complex genomic and multiomic data to actionable insightIncluded in the new
- 1mo agoILMNIllumina to Announce Third Quarter 2026 Financial Results on Thursday, October 29, 2026PR NewswireSAN DIEGO, Oct. 8, 2026 /PRNewswire/ -- Illumina, Inc. (NASDAQ:ILMN) announced today that it will issue results for the third quarter 2026 following the close of market on Thursday, October 29, 2026.On the same day, at
- 1mo agoILMNIllumina releases SpliceAI2 to help advance rare disease researchPR NewswireIn a rare disease research dataset, SpliceAI2 identified 17% more disease-relevant variants compared to other splicing modelsIllumina's genomic AI models now collectively enable researchers to identify 2x as many
- 2mo agoHYFTVEEVILMNCERT+1The Market Just Told You Which Layer Of AI Biology It Is Paying ForGlobeNewswireAUSTIN, Texas, Sept. 03, 2026 (GLOBE NEWSWIRE) -- Market Updates News Commentary - Earnings season in life sciences technology has just delivered an unusually clean verdict. The company that owns the industry’s data
- 3mo agoILMNQ2 2026 Illumina Earnings Call - ILLUMINA INCEarnings Call TranscriptsGood day, ladies and gentlemen. Welcome to the second quarter 2026 Illumina earnings conference call. At this time, all participants are in a listen only mode. After the speaker's presentation, we will conduct a question
- 3mo agoILMNIllumina Reports Financial Results for Second Quarter of Fiscal Year 2026PR NewswireIllumina, Inc. (Nasdaq: ILMN) ("Illumina" or the "company") today announced its financial results for the second quarter of fiscal year 2026. Second...
- 3mo agoILMNQ2 2026 Illumina Earnings Call - ILLUMINA INCEarnings Call TranscriptsGood day, ladies and gentlemen. Welcome to the second quarter 2026 Illumina earnings conference call. At this time, all participants are in a listen only mode. After the speaker's presentation, we will conduct a question
- 3mo agoILMNIllumina expands Billion Cell Atlas program with new AI drug developersPR NewswireIllumina, Inc. (NASDAQ: ILMN) today announced that the Billion Cell Atlas alliance has added three new member companies, including AI-native drug...
- 4mo agoILMNIllumina to Announce Second Quarter 2026 Financial Results on Thursday, July 30, 2026PR NewswireIllumina, Inc. (NASDAQ: ILMN) announced today that it will issue results for the second quarter 2026 following the close of market on Thursday, July...
- 4mo agoILMNIllumina appoints Michael Sullivan Chief Commercial Officer and Julie Coletti Chief Legal OfficerPR NewswireIllumina, Inc. (NASDAQ: ILMN) today announced the appointment of Mike Sullivan as Chief Commercial Officer, effective July 20, 2026, and Julie...
- 4mo agoILMNDaniel M. Skovronsky, MD, PhD, appointed to Illumina's Board of DirectorsPR NewswireIllumina, Inc. (NASDAQ: ILMN) today announced the appointment of Daniel M. Skovronsky, MD, PhD, to its Board of Directors, effective June 16, 2026....
- 4mo agoRAAQTXGILMNJDSU+2IQM Appoints Craig Ciesla, Former Illumina VP, as CTO; Inés de Vega Becomes Chief ScientistBusiness WireCiesla is a seasoned deep tech executive with more than 25 years of experience delivering products across industries — from startups to Fortune 500 companies. De Vega brings more than 20 years of experience
- 5mo agoILMNIllumina launches StrataMap Spatial Solution, a powerful end-to-end spatial whole transcriptome research solutionPR NewswireIllumina, Inc. (NASDAQ: ILMN) today announced the launch of the StrataMap Spatial Solution, offering an unmatched breadth of coverage and resolution...
- 5mo agoILMNIntegrated DNA Technologies Announces End-to-End Oncology Research Workflows Optimized on Illumina Software for Faster InsightsBusiness WireIntegrated, push-button oncology research workflows give customers a simplified path from library prep through DRAGEN™-powered secondary analysis DRAGEN™ pipelines optimized for IDT custom hybrid
- 5mo agoILMNIllumina and SPT Labtech unveil fireflyGO, enabling faster, simpler targeted oncology researchPR NewswireIllumina, Inc. (NASDAQ: ILMN) and SPT Labtech today introduced the fireflyGO automation platform, a new benchtop liquid handling and library...
- 5mo agoILMNIllumina introduces the first distributed whole-genome sequencing solution for highly sensitive MRD researchPR NewswireIllumina, Inc. (NASDAQ: ILMN) today announced a new complete solution for molecular residual disease (MRD) research based on whole-genome sequencing...
- 5mo agoILMNDavid P. King elected to Illumina's Board of DirectorsPR NewswireIllumina, Inc. (NASDAQ: ILMN) today confirmed the election of David P. King to its Board of Directors, effective immediately following the company's...
- 5mo agoILMNIllumina releases 2025 Corporate Responsibility Report, expanding access to genomics and accelerating global impactPR NewswireIllumina Inc. (NASDAQ: ILMN) today published its annual Corporate Responsibility (CR) Report. The report highlights the company's continued progress...
- 6mo agoILMNQ1 2026 Illumina Earnings Call - ILLUMINA INCEarnings Call TranscriptsGood day, ladies and gentlemen. Welcome to the first quarter 2026 Illumina Earnings Conference Call. At this time, all participants are in a listen-only mode. After the speaker's presentation, we will conduct a question-
- 6mo agoILMNIllumina Reports Financial Results for First Quarter of Fiscal Year 2026PR NewswireIllumina, Inc. (Nasdaq: ILMN) ("Illumina" or the "company") today announced its financial results for the first quarter of fiscal year 2026. First...
- 6mo agoILMNQ1 2026 Illumina Earnings CallILLUMINA INCEarnings Call TranscriptsGood day, ladies and gentlemen. Welcome to the first quarter 2026 Illumina Earnings Conference Call. At this time, all participants are in a listen-only mode. After the speaker's presentation, we will conduct a question-
- 6mo agoILMNDRAGEN v4.5 supports Illumina's new TruPath Genome and 5-base assays, drives insights across germline, oncology, and multiomic workflowsPR NewswireIllumina Inc. (NASDAQ: ILMN) today announced the launch of DRAGEN™ version 4.5 software (v4.5), one of the most substantial expansions of the...
- 7mo agoILMNIllumina and the Center for Data-Driven Discovery in Biomedicine bring genomic data and scalable software to the fight against pediatric cancer and rare diseasePR NewswireIllumina (NASDAQ: ILMN) and the Center for Data-Driven Discovery in Biomedicine (D3b) today announced a data partnership to advance research in...
- 7mo agoILMNIllumina to Announce First Quarter 2026 Financial Results on Thursday, April 30, 2026PR NewswireIllumina, Inc. (NASDAQ:ILMN) announced today that it will issue results for the first quarter 2026 following the close of market on Thursday, April...
- 7mo agoILMNIllumina Announces Changes to Board of DirectorsPR NewswireIllumina, Inc. (NASDAQ: ILMN) today announced changes to its Board of Directors. Frances Arnold, PhD, Robert S. Epstein, MD, and Gary S. Guthart,...
- 7mo agoILMNLHIllumina and Labcorp expand collaboration to broaden access to precision oncology testingPR NewswireIllumina, Inc. (NASDAQ: ILMN) and Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, today announced an...
- 8mo agoILMNIllumina advances preventive genomics through strategic consortium with Veritas GeneticsPR NewswireIllumina, Inc. (NASDAQ: ILMN) today announced a strategic collaboration with Veritas Genetics Powered By Fuze Health to form a consortium that aims...
- 8mo agoILMNAlliance for Genomic Discovery expands with Regeneron Genetics Center membership and new proteomics data offeringPR NewswireIllumina, Inc. (NASDAQ: ILMN), and Nashville Biosciences, LLC (NashBio), today announced two advancements in scale and depth of the Alliance for...
- 8mo agoILMNIllumina whole-genome sequencing technology to accelerate rare disease testing in FloridaPR NewswireIllumina, Inc. (NASDAQ: ILMN) today announced that Illumina Laboratory Services, Illumina's CLIA-certified laboratory, is providing clinical...
- 8mo agoILMNIllumina partners go beyond the genome, driving cancer breakthroughs using spatial transcriptomics, epigenomics, and proteomicsPR NewswireIllumina, Inc. (NASDAQ: ILMN) today announced new customer breakthroughs in oncology powered by Illumina's spatial transcriptomics, 5-base...
- 8mo agoILMNIllumina launches TruPath Genome, setting a new standard in genomic insightPR NewswireIllumina, Inc. (NASDAQ: ILMN) today announced the launch of TruPath™ Genome, setting a new standard for high-quality, comprehensive whole genome...
- 8mo agoILMNIllumina unveils roadmap of groundbreaking NovaSeq X advancements in data quality, output, speed, and flexibilityPR NewswireIllumina, Inc. (NASDAQ: ILMN) today unveiled an 18-month roadmap of innovations that enhance the power and value of the NovaSeq X system. Updates...
- 8mo agoILMNIllumina To Webcast Upcoming Investor ConferencePR NewswireIllumina, Inc. (NASDAQ: ILMN) today announced that members of its management team will participate at the following investor conference: Upcoming...
- 9mo agoGHILMNKBLBRXRXAI, Genomics, and CRISPR Signal a New Phase of Biological InnovationGlobeNewswireDENVER, Feb. 10, 2026 (GLOBE NEWSWIRE) -- As artificial intelligence continues to move beyond software and automation, its impact on genomics and gene editing is becoming increasingly tangible. Recent developments
- 9mo agoILMNQ4 2025 Illumina Earnings CallILLUMINA INCEarnings Call TranscriptsGood day, ladies and gentlemen. Welcome to the fourth quarter 2025 Illumina Earnings Conference Call. At this time, all participants are in a listen-only mode. After the speaker's presentation, we will conduct a question
- 9mo agoILMNQ4 2025 Illumina Earnings Call - ILLUMINA INCEarnings Call TranscriptsGood day, ladies and gentlemen. Welcome to the fourth quarter 2025 Illumina Earnings Conference Call. At this time, all participants are in a listen-only mode. After the speaker's presentation, we will conduct a question
- 9mo agoILMNIllumina Reports Financial Results for Fourth Quarter and Fiscal Year 2025PR NewswireIllumina, Inc. (Nasdaq: ILMN) ("Illumina" or the "company") today announced its financial results for the fourth quarter and fiscal year 2025. "The...
- 9mo agoILMNIllumina and the San Diego Zoo Wildlife Alliance partner to sequence the Frozen Zoo®, supporting critical conservation genetics efforts globallyPR NewswireIllumina, Inc. (NASDAQ: ILMN) today announced a sequencing agreement with the San Diego Zoo Wildlife Alliance (SDZWA)'s Frozen Zoo®. The 50-year-old...
- 9mo agoILMNLABStandard BioTools Completes Sale of SomaLogic to IlluminaGlobeNewswireReceived $350 Million in upfront cash at closing; Up to $425 Million in total proceeds inclusive of near-term earnout payments Approximately $550 Million in cash & cash equivalents on balance sheet at close,
- 9mo agoILMNIllumina completes acquisition of SomaLogicPR NewswireIllumina, Inc. (NASDAQ: ILMN) today announced that it has completed its acquisition of SomaLogic, a leader in data-driven proteomics technology. The...
- 9mo agoIBMAMZNUALBA+7BitsStifel Insights
- 9mo agoILMNIllumina secures CMS reimbursement for TruSight™ Oncology Comprehensive, expanding access to precision oncologyPR NewswireIllumina, Inc. (NASDAQ: ILMN) today announced that reimbursement has been granted for its FDA-approved in vitro diagnostic (IVD) TruSight™ Oncology...
- 10mo agoILMNIllumina introduces Billion Cell Atlas to accelerate AI and drug discoveryPR NewswireIllumina, Inc. (NASDAQ: ILMN) today introduced the world's largest genome-wide genetic perturbation dataset, being built to accelerate drug discovery ...